|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
1.18%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
1.14%
|
US
|
NASDAQ
|
|
VTYX
|
Ventyx Biosciences, Inc.
|
1.05%
|
US
|
NASDAQ
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
1.04%
|
US
|
NYSE
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
1.03%
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
0.97%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.96%
|
US
|
NASDAQ
|
|
SIGA
|
SIGA Technologies Inc.
|
0.94%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.68%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.57%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.49%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.33%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
0.17%
|
US
|
NASDAQ
|